Chemoreflex and Baroreflex Alterations Causing Postural Tachycardia Syndrome With Orthostatic Hyperpnea and Hypocapnia

NAUnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 23, 2022

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2024

Conditions
Postural Orthostatic Tachycardia SyndromeHypocapniaHyperventilation
Interventions
DIAGNOSTIC_TEST

Chemoreflex Testing

The carotid body chemoreflex can be tested by holding carbon dioxide (CO2) constant (isocapnic) and applying hypoxia and hyperoxia. Measurements are then made of expiratory minute volume and of sympathetic activity. The central chemoreflex measures isocapnic and hypercapnic responses in the presence of hyperoxia to suppress the carotid body chemoreflex.

DIAGNOSTIC_TEST

Baroreflex testing

Baroreceptors are measured by the change of heart rate (HR) and sympathetic activity with changing blood pressure using the modified Oxford technique. Blood pressure is lowered an amount by a bolus of sodium nitroprusside and then raised by a bolus of phenylephrine. When standing baroreflexes are activated and the investigators will measure chemoreflex activity upright to see how baroreflex effects the chemoreflexes. Similarly chemoreflexes affect the baroreflexes best observed when the patients are supine.

DIAGNOSTIC_TEST

Orthostatic stress testing

Orthostatic Stress tests are administered in two forms: a standing test to evoke the initial orthostatic hypotensive response that sensitizes and triggers the carotid body chemoreflex by intermittent stagnant ischemia. And the 70 degree upright tilt test that best identifies causal changes in regional blood volumes and flows and in respiratory patterns of hyperpneic hypocapnia.

Trial Locations (1)

10532

RECRUITING

NewYork Medical College, Hawthorne

Sponsors
All Listed Sponsors
lead

New York Medical College

OTHER